AwardTape · Defense awards · Medical · Drugs and biologicals · HT001422P0039
HT001422P0039: $557K purchase order to Sun Pharmaceutical Industries, Inc
Sun Pharmaceutical Industries, Inc holds a purchase order from Defense Health Agency with $557K obligated since Oct 2023 and $967K obligated over its life, against a ceiling of $967K. Latest action Mar 17, 2026.
Nuclear medicine imaging products for myocardial infarct imaging, diagnostic imaging of gall bladder disorders, and breast cancer nodule imaging medicine.
| PIID | HT001422P0039 |
|---|---|
| Type | purchase order |
| Company | Sun Pharmaceutical Industries, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $557K |
| Total obligated (lifetime) | $967K |
| Ceiling (base and all options) | $967K |
| Base date | Mar 10, 2022 |
| Latest action | Mar 17, 2026 |
| End date | Mar 10, 2027 |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial